Defunct Company
Total Trials
7
As Lead Sponsor
2
As Collaborator
5
Total Enrollment
33,280
NCT00466349
International SMA Patient Registry
Phase: N/A
Role: Collaborator
Start: May 31, 1986
Completion: Jan 31, 2018
NCT01638611
A Study of Subcutaneous Doses of HIP2B in Healthy Male Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 31, 2012
Completion: Sep 30, 2012
NCT01736553
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development
Start: Dec 31, 2012
Completion: Sep 30, 2015
NCT01933256
Study of Subcutaneous Doses of HIP2B in Subjects With Type 2 Diabetes Mellitus Treated With Metformin
Start: Aug 31, 2013
Completion: Dec 31, 2014
NCT04139343
Motor Unit Number Estimation (MUNE) in Adults With Spinal Muscular Atrophy (SMA)
Start: Aug 10, 2018
Completion: Dec 31, 2025
NCT04591678
Adults With SMA Treated With Nusinersen
Start: Oct 1, 2018
Completion: Jun 25, 2021
NCT03655223
Early Check: Expanded Screening in Newborns
Start: Oct 15, 2018